Calarisdx
1 known investors
Find your way into Calarisdx
Sign up to see every warm intro you have to Calarisdx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Calarisdx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Calaris develops saliva-based, point-of-care diagnostic tests for early detection of liver disease and head & neck cancer, using validated salivary biomarkers, multiplexing, and AI/ML algorithms to generate risk scores. The tests are designed for use in primary care and community health settings to enable non-invasive screening.
Investors · 1
Frequently asked questions
- What does Calarisdx do?
- Calaris develops saliva-based, point-of-care diagnostic tests for early detection of liver disease and head & neck cancer, using validated salivary biomarkers, multiplexing, and AI/ML algorithms to generate risk scores. The tests are designed for use in primary care and community health settings to enable non-invasive screening.
- Who are Calarisdx's investors?
- Calarisdx's investors include Health Wildcatters.
